Stocks
Arrowhead Pharmaceuticals (ARWR) Net margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -101.9% | -72.4% | -85.3% | -16 882% | -0.20% | -48.4% | ||
| Changes by years, y/y, % | -6pp | +29pp | -13pp | -16 797pp | +16 882pp | -71.0% | |||
Arrowhead Pharmaceuticals. Net margin, %
Arrowhead Pharmaceuticals. Net margin, changes, pp
Arrowhead Pharmaceuticals (ARWR) Net margin US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | LTM ? | |||
| Net margin, % | ? | 68.3% | -631.1% | -9.26% | 11.7% | -180.0% | -48.4% | |
| Changes by years, y/y, % | +6 935pp | -248pp | ||||||
| Changes by quarters, q/q, % | +6 992pp | -699pp | +622pp | +21pp | -192pp | |||
